Elanco Animal Health Incorporated (ELAN): Price and Financial Metrics
Elanco Animal Health Incorporated (ELAN)
Today's Latest Price: $19.89 USD
Updated Apr 2 2:24pm
Add ELAN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ELAN Stock Summary
- With a one year PEG ratio of 1,171.36, Elanco Animal Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.41% of US stocks.
- ELAN's went public 1.53 years ago, making it older than just 1.79% of listed US stocks we're tracking.
- ELAN's current price/earnings ratio is 109.23, which is higher than 96.43% of US stocks with positive earnings.
- If you're looking for stocks that are quantitatively similar to Elanco Animal Health Inc, a group of peers worth examining would be HOLX, HSTM, OTEX, AGCO, and PRGO.
- ELAN's SEC filings can be seen here. And to visit Elanco Animal Health Inc's official web site, go to www.elanco.com.
ELAN Stock Price Chart More Charts
ELAN Price/Volume Stats
| Current price | $19.89 | 52-week high | $35.46 |
| Prev. close | $20.15 | 52-week low | $15.17 |
| Day low | $19.50 | Volume | 3,137,753 |
| Day high | $20.74 | Avg. volume | 6,581,248 |
| 50-day MA | $26.50 | Dividend yield | N/A |
| 200-day MA | $28.34 | Market Cap | 7.93B |
Elanco Animal Health Incorporated (ELAN) Company Bio
Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.
ELAN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $19.89 | $0.01 | -100% |
We started the process of determining a valid price forecast for Elanco Animal Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Elanco Animal Health Inc ranked in the 0th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Elanco Animal Health Inc ended up being:
- The company's compound free cash flow growth rate over the past 1.48 years comes in at -0.62%; that's greater than only 1.3% of US stocks we're applying DCF forecasting to.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than 60.28% of stocks in its sector (Healthcare).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -100% |
| 1% | -100% |
| 2% | -100% |
| 3% | -100% |
| 4% | -100% |
| 5% | -100% |
ALC, AMPH, CSII, HAPP, and MEDS can be thought of as valuation peers to ELAN, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...